Optomed Oyj has recorded no insider trading activity within the past ninety days. The most recent transactions occurred in August 2024, involving senior managers executing both buy and sell orders. Prior to this period, the Chief Executive Officer acquired shares in March 2024. These historical movements represent the latest documented equity changes for the firm.